Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turmeric Extract for Treatment of COVID-19
IRCT20201111049348N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcuma longa extract in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
curcuma longa extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201111049348N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201111049348N2.